ARTICLES BY THIS AUTHOR

• 12/15/2015

  Innovative prostate cancer drug designed in B.C. enters clinical trials

• 12/15/2015

  U.S. pharmacy chains help clients enroll in Obamacare

  Retailers believe more Americans with health coverage mean more Americans filling prescriptions.
• 12/14/2015

  Cross-border body scans slammed by Canadian doctors

• 12/14/2015

  Taking antidepressants during pregnancy appears to raise autism risk: study

  Montreal study finds taking antidepressants of any kind while pregnant somewhat boosts risk.
• 12/14/2015

  ‘You have been randomly selected for peer review’

• 12/14/2015

  What your patients are reading – Week of December 14, 2015

• 12/14/2015

  Canadians should modernize, not privatize, medicare

• 12/14/2015

  Nova Scotia's doctors may be stripped of their right to binding arbitration

• 12/14/2015

  New developments in the pharmacotherapy of hepatitis C

  Over the past five years, the treatment of chronic hepatitis C virus (HCV) infection has changed dramatically with the development of direct-acting antiviral (DAA) agents that target various phases of the HCV lifecycle. This article outlines the current pharmacological management of HCV infection, with a focus on first-line genotype 1 treatment options.
• 12/14/2015

  Press Review – December 15, 2015